Publication | Closed Access
Halofuginone Ameliorates Autoimmune Arthritis in Mice by Regulating the Balance Between Th17 and Treg Cells and Inhibiting Osteoclastogenesis
35
Citations
42
References
2013
Year
Taken together, our results suggest that halofuginone is a promising therapeutic agent for the treatment of Th17 cell-mediated inflammatory diseases and bone diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1